Jaywoo Kim, Executive Vice President of Samsung C&T Corporation, says, "Since Samsung C&T stepped into the life sciences industry by investing in biologics CDMO and biosimilar business, it has ...

A St. Louis-based company known for its work in Alzheimer's and neurological testing can expand its footprint, thanks to a $10 million investment from several life sciences companies.

Jaywoo Kim, Executive Vice President of Samsung C&T Corporation, says, "Since Samsung C&T stepped into the life sciences industry by investing in biologics CDMO and biosimilar business, it has ...

C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said the cash injection would help to scale its clinical laboratory ...

Wauwatosa, Wisconsin, and St. Louis, MO, March 25, 2025 (GLOBE NEWSWIRE) -- Splash Clinical, the new standard in trial enrollment, and C2N Diagnostics, LLC (“C2N”), a pioneer in advanced ...

Samsung C&T announced Thursday that its Life Science Fund, established in collaboration with Samsung Biologics, Samsung Bioepis and Samsung Venture Investment, will invest $10 million in C2N ...

The first-of-its-kind partnership combines Splash's recruitment platform with C2N's innovative blood tests to accelerate clinical research and improve patient experience. Wauwatosa, Wisconsin, and St.

C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a $10 million USD investment from Samsung C&T Corporation ...